The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMediumUpdated•Originally published 13 April 2026•Updated 14 April 2026•

1 min read

Stryker to Acquire Amplitude Vascular Systems to Bolster Cardiovascular Portfolio

Canadian flag, a plasma bag, and "GRIFOLS" text on an orange background with medical equipment, microscopes, and vials.

Key Facts

1Stryker agreed to acquire Amplitude Vascular Systems (AVS), a firm specializing in intravascular lithotripsy (IVL) technology.

about 2 months ago

Version History

1 additional source confirmed this story

Version 1about 2 months ago

What changed: Added details regarding Stryker's headquarters, AVS's status as a privately held company, and the pivotal trial status of the Pulse IVL system.

Stryker (NYSE:SYK), headquartered in Portage, Michigan, has signed a definitive agreement to acquire Amplitude Vascular Systems (AVS), a privately held medical technology firm specializing in intravascular lithotripsy (IVL). The acquisition is designed to integrate the Pulse IVL system, which is currently undergoing pivotal trials, into Stryker’s cardiovascular treatment offerings. By incorporating AVS's technology, Stryker aims to strengthen its peripheral vascular portfolio and expand its footprint in high-growth medical markets. This strategic move positions the company to compete more effectively against industry rivals such as Johnson & Johnson and Boston Scientific. While the acquisition marks a significant expansion, the specific financial terms of the deal were not disclosed. The transaction underscores Stryker's commitment to advancing treatments for complex artery diseases through targeted innovation.